| |
| |
|
| Insider
Information: |
Mainolfi Nello |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
615,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
615,570 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-01-02 |
615,570 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
376,199 |
|
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-08 |
4 |
AS |
$50.00 |
$13,500 |
D/D |
(270) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-08 |
4 |
OE |
$2.08 |
$562 |
D/D |
270 |
412,469 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-19 |
4 |
AS |
$40.00 |
$26,121 |
D/D |
(653) |
391,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-23 |
4 |
AS |
$40.01 |
$27,208 |
D/D |
(680) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-23 |
4 |
OE |
$2.08 |
$1,414 |
D/D |
680 |
397,879 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-29 |
4 |
AS |
$60.00 |
$40,800 |
D/D |
(680) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-29 |
4 |
OE |
$2.08 |
$1,414 |
D/D |
680 |
452,879 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
AS |
$60.03 |
$62,253 |
D/D |
(1,037) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
OE |
$2.08 |
$2,157 |
D/D |
1,037 |
453,236 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-26 |
4 |
OE |
$2.08 |
$5,757 |
D/D |
2,768 |
399,967 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-26 |
4 |
AS |
$40.18 |
$111,229 |
D/D |
(2,768) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-28 |
4 |
OE |
$2.08 |
$8,037 |
D/D |
3,864 |
456,063 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-28 |
4 |
AS |
$60.15 |
$232,410 |
D/D |
(3,864) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-15 |
4 |
OE |
$2.08 |
$10,275 |
D/D |
4,940 |
396,139 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-15 |
4 |
AS |
$40.29 |
$199,039 |
D/D |
(4,940) |
391,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-03 |
4 |
OE |
$2.08 |
$11,792 |
D/D |
5,669 |
457,868 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-03 |
4 |
AS |
$60.07 |
$340,533 |
D/D |
(5,669) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-09 |
4 |
OE |
$2.08 |
$11,964 |
D/D |
5,752 |
417,951 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-09 |
4 |
AS |
$50.02 |
$287,721 |
D/D |
(5,752) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-30 |
4 |
OE |
$2.08 |
$13,060 |
D/D |
6,279 |
458,478 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-30 |
4 |
AS |
$60.07 |
$377,167 |
D/D |
(6,279) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-11 |
4 |
OE |
$2.08 |
$13,428 |
D/D |
6,456 |
470,655 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-11 |
4 |
AS |
$53.58 |
$346,590 |
D/D |
(6,456) |
464,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-19 |
4 |
OE |
$2.08 |
$13,838 |
D/D |
6,653 |
397,199 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
